Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
Add more filters










Publication year range
1.
Emerg Radiol ; 28(5): 985-992, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34189656

ABSTRACT

PURPOSE: Recent updates in national guidelines for management of acute ischemic stroke in patients of unknown time of symptom onset ("wake-up" strokes) incorporate, for the first time, use of emergent MRI. In this retrospective case series, we analyze our experience at a Comprehensive Stroke Center implementing a new workflow including MRI in this clinical setting. This study also describes "DWI-FLAIR" mismatch, a critical concept for the interpretation of emergent brain MRIs performed for wake-up strokes. METHODS: Over a 14-month period, all brain MRIs for wake-up stroke were identified. The imaging was analyzed by two board-certified, fellowship-trained neuroradiologists, and a diagnosis of DWI-FLAIR mismatch was made by consensus. Process metrics assessed included interval between last known well time and brain imaging, interval between CT and MRI, and interval between brain MRI and interpretation. RESULTS: Sixteen patients with a history of "wake-up stroke" were identified. Thirteen of the 16 patients (81.3%) were found to have a DWI-FLAIR mismatch, suggesting infarct < 4.5 h old. The mean time between last known well and MRI was 7.89 h with mean interval between CT and MRI of 1.83 h. Forty-six percent of patients with DWI-FLAIR mismatch received intravenous thrombolysis. CONCLUSION: In this "real world" assessment of incorporation of emergent MRI for wake-up strokes, there were several key factors to successful implementation of this new workflow, including effective and accurate description of MRI findings; close collaboration amongst stakeholders; 24/7 availability of MRI; and 24/7 onsite coverage by neurology and radiology physicians.


Subject(s)
Brain Ischemia , Ischemic Stroke , Stroke , Diffusion Magnetic Resonance Imaging , Humans , Magnetic Resonance Imaging , Retrospective Studies , Stroke/diagnostic imaging , Time Factors
2.
Toxicol Pathol ; 45(7): 1012-1021, 2017 10.
Article in English | MEDLINE | ID: mdl-29020890

ABSTRACT

In the constantly evolving field of toxicologic pathology, a pathologist's career is often characterized by multiple career transitions. However, these transitions can be challenging and/or overwhelming and may require a shift in focus, strategic approach, and acquisition of new skills and expertise. In order to provide a forum to discuss challenges associated with career transitions and skill set/competencies required to navigate career changes effectively and successfully, the Career Development and Outreach Committee of the Society of Toxicologic Pathology (STP) sponsored a career development workshop entitled "Transitions in a Pathologist's Career" in conjunction with the STP 36th annual symposium. The presentations at this workshop provided perspectives of managers from pharmaceutical companies and Contract Research Organizations as well as consultants. This article is designed to provide brief summaries of their talks in this well-received career development workshop.


Subject(s)
Career Mobility , Pathology , Toxicology , Humans , Pathology, Clinical/education , Societies, Scientific , Translational Research, Biomedical
3.
Surg Obes Relat Dis ; 13(4): 701-704, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28089592

ABSTRACT

BACKGROUND: Laparoscopic sleeve gastrectomy (SG) as a single-stage procedure for the treatment of morbid obesity is becoming increasingly popular. In undeveloped countries, the linear staples required to create the sleeve are not always available because of their high cost. As an alternative to the staples, the bipolar vessel sealer device could be used in bariatric surgery to divide and temporarily seal the stomach. SETTINGS: Universidad Central de Venezuela, Caracas, Venezuela. METHODS: Between May 2015 and July 2016, 9 patients with a mean body mass index of 38.2 kg/m2 were submitted to a stapleless laparoscopic SG using the bipolar vessel sealer for the gastric division. The sleeve was performed over a 42 French bougie and closed with 2 layers of running sutures. Surgical time, morbidity, hospital stay, and excess weight loss were prospectively collected. RESULTS: Mean operative time and hospital stay were 117 min and 2.3 days. There was no major morbidity but 2 patients presented a basal atelectasis, which was solved by medical treatment without consequences. After a mean follow up of 6.8 months the mean excess weight loss was 78.4%. CONCLUSION: The technique of stapleless laparoscopic SG presented in this report is a valid alternative when these devices are not available. Large series with long-term follow-up are necessary to make definitive conclusions.


Subject(s)
Gastrectomy/methods , Laparoscopy/methods , Obesity, Morbid/surgery , Surgical Stapling/methods , Weight Loss , Adult , Body Mass Index , Female , Follow-Up Studies , Humans , Male , Middle Aged , Obesity, Morbid/physiopathology , Retrospective Studies , Time Factors , Treatment Outcome
4.
Rev. Nac. (Itauguá) ; 8(2): 81-93, dic 2016.
Article in Spanish | LILACS, BDNPAR | ID: biblio-884762

ABSTRACT

RESUMEN La malformación arteriovenosa uterina (MAVU) es una causa poco frecuente de sangrado uterino, dado que en la mayoría de casos cursa de forma asintomática. Las MAVU son dilataciones varicosas arteriovenosas intramiometriales sin afectación capilar. Plantean un reto diagnóstico y terapéutico en el esfuerzo de la preservación de la fertilidad, constituyéndose la embolización como su principal tratamiento. En la actualidad, el estándar de oro para el diagnóstico de esta patología es la angiografía. Sin embargo, las modalidades menos invasivas como la ecografía Doppler color se utilizan cada vez más para el diagnóstico. Se presenta el caso de una mujer de 20 años de edad, con antecedente de embarazo molar y sangrado menstrual excesivo debido a MAVU.


ABSTRACT Uterine arteriovenous malformation (AVMV) is a rare cause of uterine bleeding, since most cases are asymptomatic. The MAVU are intramyometrial arteriovenous variceal dilatations without capillary involvement. They propouse a diagnostic and therapeutic challenge in the effort for preservation of fertility, constituting the embolization its main treatment. At present, the gold standard for the diagnosis of this pathology is angiography. However, less invasive modalities such as color Doppler ultrasound are increasingly used for diagnosis. We present the case of a 20-year-old woman with a history of molar pregnancy and excessive menstrual bleeding due to MAVU.


Subject(s)
Humans , Female , Adult , Young Adult , Arteriovenous Malformations/therapy , Arteriovenous Malformations/diagnostic imaging , Uterine Artery Embolization , Uterine Artery/abnormalities , Angiography , Magnetic Resonance Spectroscopy , Ultrasonography, Doppler, Color , Uterine Artery/diagnostic imaging
5.
Toxicol Pathol ; 43(5): 733-6, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25391311

ABSTRACT

Examination of H&E-stained tongue samples from a 26-week intravenous infusion study of Beagle dogs, utilizing a compound with no recognized effect on mineral metabolism, exhibited superficial stratum corneum calcification in both treated and control animals. This resulted in the search for possible causes of the finding to help clarify confounding issues. Retrospective examination of 11 studies performed before the signal case indicated that the problem existed in the testing facility but was not recognized. Prior to 2008, this finding was not observed, perhaps indicating the requirement for a change in procedures or suppliers. Based on the hypothesis that the calcium salts were deposited from bone during processing, a series of tests was performed by fixing tongue and femur along with different tissues, processed routinely to slide, and stained with H&E and von Kossa stains. We conclude that the presence of superficial stratum corneum calcification of the tongue in dogs demonstrated in toxicology studies is an artifactual change related to the processing of tissues, specifically the fixation of tongue in the same container as bone and stomach. This change should not be confused with compound-related effects, even when the incidence varies between controls and treated animals.


Subject(s)
Artifacts , Dogs/metabolism , Histological Techniques/veterinary , Tongue/metabolism , Animals , Female , Histological Techniques/methods , Histological Techniques/standards , Male , Pathology , Retrospective Studies , Specimen Handling , Tongue/pathology , Toxicology
6.
PLoS One ; 9(12): e115155, 2014.
Article in English | MEDLINE | ID: mdl-25521914

ABSTRACT

High dose rate brachytherapy (HDR) using 192Ir sources is well accepted as an important treatment option and thus requires an accurate dosimetry standard. However, a dosimetry standard for the direct measurement of the absolute dose to water for this particular source type is currently not available. An improved standard for the absorbed dose to water based on Fricke dosimetry of HDR 192Ir brachytherapy sources is presented in this study. The main goal of this paper is to demonstrate the potential usefulness of the Fricke dosimetry technique for the standardization of the quantity absorbed dose to water for 192Ir sources. A molded, double-walled, spherical vessel for water containing the Fricke solution was constructed based on the Fricke system. The authors measured the absorbed dose to water and compared it with the doses calculated using the AAPM TG-43 report. The overall combined uncertainty associated with the measurements using Fricke dosimetry was 1.4% for k = 1, which is better than the uncertainties reported in previous studies. These results are promising; hence, the use of Fricke dosimetry to measure the absorbed dose to water as a standard for HDR 192Ir may be possible in the future.


Subject(s)
Brachytherapy/standards , Ferrous Compounds/radiation effects , Iridium Radioisotopes/therapeutic use , Radiometry/methods , Solutions/radiation effects , Absorption, Radiation , Algorithms , Brachytherapy/methods , Feasibility Studies , Radiotherapy Dosage/standards , Water/chemistry
7.
Int J Toxicol ; 33(3): 162-174, 2014 05.
Article in English | MEDLINE | ID: mdl-24801488

ABSTRACT

Historically, nitrogen oxides (NOx) in food, drinking water, as well as in the atmosphere have been believed to be associated with adverse health consequences. More recently, NOx have been implicated in normal homeostatic regulation, and exogenous administration has been associated with health benefits. One such potential health benefit is the prospect that inhaled nitrite will lower pulmonary blood pressure (BP) in patients with pulmonary arterial hypertension (PAH), a disease with poor prognosis due to the lack of effective treatment. To characterize potential chronic toxicity associated with inhaled AIR001 (sodium nitrite) for use in the treatment of PAH, 26-week exposures to AIR001 were carried out by inhalation administration in rats and by intravenous infusion in dogs. The studies revealed that methemoglobinemia was the primary adverse effect in both species. Methemoglobin levels less than 40% were well tolerated in both species, while levels greater than 50% methemoglobin caused death in some rats. Additionally, a decrease in systemic BP was also observed with inhaled AIR001 exposure in dogs. These acute secondary and exaggerated pharmacological effects occurred daily throughout the 26-week treatment period. Chronic exposure did not alter the magnitude of either methemoglobinemia or hypotension or result in additional toxicity or compensatory responses. Based on the exposure levels that produced these pharmacodynamic responses in animals, relative to those measured in early clinical studies, it appears that an adequate margin of safety exists to support the continued clinical development of inhaled AIR001.


Subject(s)
Antihypertensive Agents/adverse effects , Drugs, Investigational/adverse effects , Nasal Cavity/drug effects , Nasal Mucosa/drug effects , Sodium Nitrite/adverse effects , Administration, Inhalation , Animals , Animals, Inbred Strains , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/therapeutic use , Dogs , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Drugs, Investigational/administration & dosage , Drugs, Investigational/therapeutic use , Female , Hypertension, Pulmonary/drug therapy , Hypotension/blood , Hypotension/chemically induced , Hypotension/metabolism , Hypotension/pathology , Infusions, Intravenous , Male , Methemoglobinemia/blood , Methemoglobinemia/chemically induced , Methemoglobinemia/metabolism , Methemoglobinemia/pathology , Nasal Cavity/immunology , Nasal Cavity/metabolism , Nasal Cavity/pathology , Nasal Mucosa/immunology , Nasal Mucosa/metabolism , Nasal Mucosa/pathology , No-Observed-Adverse-Effect Level , Rats, Sprague-Dawley , Risk Assessment , Sodium Nitrite/administration & dosage , Sodium Nitrite/therapeutic use , Species Specificity , Toxicity Tests, Chronic
8.
Eur J Dermatol ; 23(5): 618-28, 2013.
Article in English | MEDLINE | ID: mdl-24225049

ABSTRACT

BACKGROUND: The Toll-like receptor 7 (TLR7) activator imiquimod (IMQ) is safe and effective in treating actinic keratosis; however, an intermittent treatment regimen is necessary because of excessive local reactions. OBJECTIVES: To evaluate in vitro potency, pharmacodynamics/pharmacokinetics, toxicity and efficacy in vivo of the newly developed TLR7 ligand-phospholipid conjugate, TMX-202, in a gel formulation. MATERIAL AND METHODS: The effects of TMX-202 were assessed both in vitro on a murine macrophage cell line and in primary bone marrow-derived dendritic cells and in vivo on mice (C57BL/6-wild type, Myd88(-/-) and Tlr7(-/-)). RESULTS: TMX-202 was more potent than IMQ in vitro using murine and human cells. In contrast, in vivo it showed less systemic pro-inflammatory activity and better safety than IMQ. Moreover, the TMX-202 gel formulation exhibited at least comparable efficacy to Aldara in a mouse model for skin proliferative diseases. CONCLUSION: TMX-202 is safe and efficacious without causing excessive adverse effects, suggesting that it may be an alternative to Aldara for the treatment of proliferative skin conditions.


Subject(s)
Adenine/analogs & derivatives , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Cell Proliferation/drug effects , Glycerophospholipids/pharmacology , Glycerophospholipids/therapeutic use , Keratosis, Actinic/drug therapy , Membrane Glycoproteins/genetics , Toll-Like Receptor 7/genetics , Adenine/blood , Adenine/pharmacology , Adenine/therapeutic use , Aminoquinolines/blood , Aminoquinolines/pharmacology , Animals , Antineoplastic Agents/blood , Cell Line , Chemotactic Factors/blood , Dendritic Cells/physiology , Gels/pharmacology , Gels/therapeutic use , Glycerophospholipids/blood , Humans , Imiquimod , Interferon-gamma/metabolism , Interleukin-1/metabolism , Interleukin-6/metabolism , Keratinocytes/physiology , Keratosis, Actinic/genetics , Leukocytes, Mononuclear/drug effects , Macrophages/physiology , Maximum Tolerated Dose , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Myeloid Differentiation Factor 88/genetics , Proto-Oncogene Proteins c-myc/genetics , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/metabolism
9.
Toxicol Pathol ; 41(3): 552-3, 2013.
Article in English | MEDLINE | ID: mdl-22821368

ABSTRACT

Adding a few animals to a toxicology study in order to document whether any lesions observed are reversible and at what level is a common practice but it is often unjustified, as most of the findings observed, particularly in the early stages of drug development, are easily categorized in regard to reversibility potential. The scientific application of all knowledge regarding the compound and the lesion in question is necessary to develop specific studies to address reversibility when this is a necessary step.


Subject(s)
Drug Evaluation, Preclinical/methods , Toxicity Tests/methods , Animals , Drug Discovery , Humans , Research Design , Risk Assessment
10.
Toxicol Pathol ; 40(2): 321-44, 2012.
Article in English | MEDLINE | ID: mdl-22089839

ABSTRACT

The 2011 annual National Toxicology Program (NTP) Satellite Symposium, entitled "Pathology Potpourri," was held in Denver, Colorado in advance of the Society of Toxicologic Pathology's 30th Annual Meeting. The goal of the NTP Symposium is to present current diagnostic pathology or nomenclature issues to the toxicologic pathology community. This article presents summaries of the speakers' presentations, including diagnostic or nomenclature issues that were presented, along with select images that were used for audience voting or discussion. Some lesions and topics covered during the symposium include: proliferative lesions from various fish species including ameloblastoma, gas gland hyperplasia, nodular regenerative hepatocellular hyperplasia, and malignant granulosa cell tumor; spontaneous cystic hyperplasia in the stomach of CD1 mice and histiocytic aggregates in the duodenal villous tips of treated mice; an olfactory neuroblastoma in a cynomolgus monkey; various rodent skin lesions, including follicular parakeratotic hyperkeratosis, adnexal degeneration, and epithelial intracytoplasmic accumulations; oligodendroglioma and microgliomas in rats; a diagnostically challenging microcytic, hypochromic, responsive anemia in rats; a review of microcytes and microcytosis; nasal lesions associated with green tea extract and Ginkgo biloba in rats; corneal dystrophy in Dutch belted rabbits; valvulopathy in rats; and lymphoproliferative disease in a cynomolgus monkey.


Subject(s)
Pathology , Toxicology , Animals
11.
Toxicol Pathol ; 37(7): 992-6, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19820139

ABSTRACT

The June 2009 Town Hall meeting of the Society of Toxicologic Pathology (STP) and a subsequent survey considered whether or not STP should endorse a published proposal (Toxicol Pathol 37: 553-561, 2009) by the International Federation of Societies of Toxicologic Pathologists (IFSTP) to provide global recognition by credential review for toxicologic pathologists engaged in regulatory-type, nonclinical toxicology studies. One-third (374 of 1082) of STP members answered the survey. The majority of respondents rejected the IFSTP proposal (55% against) but favored the concept of global recognition (57% for), if available to both anatomic pathologists and clinical pathologists (67% for). Members preferred recognition by credential review (49% for) or via an internationally authored "best practices" document detailing the ideal educational and work experiences required for entry-level proficiency in toxicologic pathology (43% for). Therefore, the STP Executive Committee does not endorse the current IFSTP proposal but will continue discussions on global recognition of qualified toxicologic pathologists with other societies of toxicologic pathology.


Subject(s)
Credentialing , Internationality , Pathology/standards , Societies, Scientific , Toxicology/standards , Data Collection
14.
J Pharmacol Exp Ther ; 327(3): 620-33, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18772321

ABSTRACT

Recent evidence suggests that the P2X(7) receptor may play a role in the pathophysiology of preclinical models of pain and inflammation. Therefore, pharmacological agents that target this receptor may potentially have clinical utility as anti-inflammatory and analgesic therapy. We investigated and characterized the previously reported P2X(7) antagonist N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, hydrochloride salt (AACBA; GSK314181A). In vitro, AACBA was a relatively potent inhibitor of both human P2X(7)-mediated calcium flux and quinolinium,4-[(3-methyl-2(3H)-benzoxazolylidene)methyl]-1-[3-(triemethylammonio)propyl]-diiodide (YO-PRO-1) uptake assays, with IC(50) values of approximately 18 and 85 nM, respectively. Compared with the human receptor, AACBA was less potent at the rat P2X(7) receptor, with IC(50) values of 29 and 980 nM in the calcium flux and YO-PRO-1 assays, respectively. In acute in vivo models of pain and inflammation, AACBA dose-dependently reduced lipopolysaccharide-induced plasma interleukin-6 release and prevented or reversed carrageenan-induced paw edema and mechanical hypersensitivity. In chronic in vivo models of pain and inflammation, AACBA produced a prophylactic, but not therapeutic-like, prevention of the clinical signs and histopathological damage of collagen-induced arthritis. Finally, AACBA could not reverse L(5) spinal nerve ligation-induced tactile allodynia when given therapeutically. Consistent with previous literature, these results suggest that P2X(7) receptors do play a role in animal models of pain and inflammation. Further study of P2X(7) antagonists both in preclinical and clinical studies will help elucidate the role of the P2X(7) receptor in pain and inflammatory mechanisms and may help identify potential clinical benefits of such molecules.


Subject(s)
Adamantane/analogs & derivatives , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Benzamides/pharmacology , Inflammation/drug therapy , Pain/drug therapy , Purinergic P2 Receptor Antagonists , Adamantane/pharmacology , Animals , Arthritis/chemically induced , Arthritis/drug therapy , Benzoxazoles , Calcium/metabolism , Disease Models, Animal , Humans , Inhibitory Concentration 50 , Quinolinium Compounds , Rats , Receptors, Purinergic P2X7
16.
Radiother Oncol ; 82(2): 222-8, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17267060

ABSTRACT

BACKGROUND AND PURPOSE: A new phantom is proposed for measuring the strength of 192Ir high dose rate sources and for verification of the dose calculated by the treatment planning system. The complete formalism and measurement procedure for this phantom is described, as well as the preliminary results obtained in a number of centers around Brazil. MATERIALS AND METHODS: The measurements are performed using powder thermoluminescent dosimeter capsules; the source strength is measured in air and the verification of the dose calculation algorithm in water phantom. The correction factors required to take into account the specificities related to the geometry and the phantom materials have been assessed using the PENELOPE Monte Carlo code and experimental methods. The dedicated phantom, constructed to use as part of a QA program, in this case specifically for high dose rate 192Ir brachytherapy sources, allows simultaneous irradiation of three thermoluminescent dosimeter capsules, requiring only one source stop (dwell positions). RESULTS: The phantom was mailed to seven radiotherapy institutions in Brazil, and the results show its usefulness in verifying the source air kerma and correctness of treatment planning dose calculation in water phantom. CONCLUSIONS: The comparison made between the phantom measurements, the well-type ionization chamber, and source specifications stated by the hospital (most of the times provided by the source manufacturer) agreed within 3% showing the quality in the HDR dose delivery in Brazilian radiotherapy centers.


Subject(s)
Brachytherapy/standards , Iridium Radioisotopes/standards , Phantoms, Imaging , Radiotherapy Dosage/standards , Algorithms , Calibration , Humans , Quality Control
17.
J Neurosci Methods ; 159(2): 291-9, 2007 Jan 30.
Article in English | MEDLINE | ID: mdl-16949674

ABSTRACT

The neurotoxin MPTP is widely used to cause damage to the dopaminergic system in rodents and non-human primates to model various aspects of Parkinson's disease. In mice, depletion of striatal dopamine is the commonly used endpoint to assess neuronal damage. However, it has proved technically challenging to quantify dopaminergic cell bodies as an index of neuronal integrity. To meet this challenge, we applied laser pressure catapult microdissection (LCM) of the substantia nigra in combination with quantitative Western blot to provide an index of dopamine neurodegeneration in mice treated with MPTP. Seven days following initiation of MPTP treatment, striatal dopamine depletion was maximal and there was histological evidence of neuronal degeneration in the substantia nigra. To index the integrity of dopamine cell bodies, tyrosine hydroxylase (TH) and beta-actin were quantified by Western blot in LCM extracts. In untreated mice, TH was detected in LCM extracts of substantia nigra but was undetectable in equivalently sized extracts of cortex from the same animals. In MPTP-treated mice, there was a significant 70% reduction in TH relative to beta-actin in LCM extracts as compared to vehicle-injected controls. This reduction corresponded to decreases in striatal dopamine and loss of immunocytochemically detected TH but not beta-actin in the substantia nigra (SN). Thus, this method provides a quantitative means to measure dopamine neuron toxicity in the substantia nigra and, as such has potential application in evaluating regimens that may be neuroprotective or neurorestorative for dopaminergic neurons.


Subject(s)
Lasers , MPTP Poisoning/pathology , Microdissection/instrumentation , Microdissection/methods , Substantia Nigra/pathology , Animals , Blotting, Western/methods , Dopamine/metabolism , Immunohistochemistry/methods , Male , Mice , Mice, Inbred C57BL , Nerve Degeneration/pathology , Tyrosine 3-Monooxygenase/metabolism
18.
Toxicol Pathol ; 31(6): 682-8, 2003.
Article in English | MEDLINE | ID: mdl-14585737

ABSTRACT

Accurate interpretation of microscopic changes in tissues is critical in hazard identification and risk assessment. To address a possible confounder, the effects of postmortem interval on hepatocyte vacuolation and liver weight were studied in fasted and nonfasted Sprague-Dawley rats. Male and female rats (5/sex/interval) were euthanized with CO2, weighed, and necropsied either immediately or after remaining in the closed CO2 chamber for 5, 10, or 25 minutes after respirations ceased. The liver was removed, weighed, and fixed for light microscopy, immunohistochemistry, and electron microscopy. The liver weight and liver to body weight ratio increased significantly in both male and female rats. Postmortem hepatocellular vacuolation was more prominent in males than in females. Both fasted and nonfasted males were similarly affected, however, fasted females were affected more than nonfasted females at the 25-minute interval. Ultrastructurally, intracytoplasmic vacuoles in hepatocytes and/or endothelial cells contained electron-lucent material that was morphologically similar to plasma in sinusoidal spaces. Results of our study suggest that hepatocyte vacuoles were formed in a postmortem time-dependent manner as a result of plasma influx into the cytoplasm. This change was associated with hepatic sinusoidal congestion and increases in liver weight. Males were more sensitive than females to postmortem hepatocyte vacuolation.


Subject(s)
Autolysis , Hepatocytes/ultrastructure , Liver/cytology , Vacuoles/ultrastructure , Animals , Female , Food Deprivation , Hepatocytes/physiology , Liver/physiology , Male , Microscopy, Electron , Morphogenesis , Organ Size , Rats , Rats, Sprague-Dawley , Sex Factors , Time Factors , Vacuoles/physiology
19.
Toxicol Pathol ; 30(1): 147-56, 2002.
Article in English | MEDLINE | ID: mdl-11890468

ABSTRACT

ILSI-HESI sponsored an international consortium for the evaluation of alternative models, including the TrpS3+/- mouse. for use in short-term carcinogenicity testing of pharmaceuticals. Products of the ILSI evaluation included guidance for protocol design and assay interpretation, spontaneous tumor incidences, diagnostic criteria for common proliferative lesions, and results of assays for pharmaceutical agents that are known human and/or rodent carcinogens and non-carcinogens. Based on the ILSI evaluation, recommended protocol elements for this model include: 26-week study duration, groups > or = 15/sex/dose, a positive control group (benzene or p-cresidine), a negative control group and 3 dose groups, the high dose set at MTD or MFD, routine in-life evaluations, and complete necropsies with microscopic evaluation of tissues. Favored statistical analyses are trend tests or pair-wise comparisons, with no adjustments for survival. For an assay to be valid, positive control groups must demonstrate an effect, and the MTD or MFD must be reached in both sexes. Criteria for a negative response include a valid assay, no statistical increase in common tumors, no biologically significant numerical increase in rare tumors, and no tumor incidence above that of historical controls. Positive responses can consist of statistically significant increases in the incidence of a common tumor or numerical increases in a rare tumor, which may not be statistically significant. In either case, the incidence should be clearly above historical control values. Evidence of a dose response or occurrence of hyperplasia in a tissue with a neoplastic response can support interpreting an assay as positive. The two most common spontaneous tumors (> 1 %) in Trp53+/- mice are malignant thymic lymphomas and subcutaneous sarcomas. Use of implanted electronic transponders can increase the incidence of sarcomas. Important rare spontaneous tumors (incidence < or = 1%) are osteosarcomas and pulmonary adenomas. Many other tumor types have been reported to occur sporadically in Trp53+/- mice. Diagnostic challenges for this model include differentiating lymphoma from atypical thymic hyperplasia and recognizing the variable histopathology of subcutaneous sarcomas. In reported bioassays, Trp53+/- mice responded positively to genotoxic carcinogens, negatively to non-genotoxic rodent carcinogens, and negatively to noncarcinogens, indicating that unlike the 2-year mouse assay, this short-term assay is not overly sensitive. Positive responses often elicited an increase in tumors that occur spontaneously. To successfully use this model, pathologists must understand the biology of the Trp53 tumor suppressor gene and the principles of protocol design and data interpretation for short-term bioassays. They must also know the historical response pattern of Trp53+/- mice to test agents and be able to accurately diagnose tumors in this model. Use of the Trp53+/- mouse presents the pharmaceutical industry with several challenges, one of which is managing the uncertainty created by a lack of precedents for regulatory decisions about some possible outcomes for short-term carcinogenicity assays.


Subject(s)
Carcinogenicity Tests/methods , Genes, Tumor Suppressor , Genes, p53/genetics , Mice, Transgenic/physiology , Pathology/methods , Pharmacology/methods , Animals , Biological Assay , Drug Industry , Mice , Neoplasms/chemically induced , Neoplasms/epidemiology , Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...